Opus Genetics
IRD
33 hedge funds and large institutions have $7.3M invested in Opus Genetics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 6 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 2
128% more capital invested
Capital invested by funds: $3.2M → $7.3M (+$4.1M)
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
6% more funds holding
Funds holding: 31 → 33 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$793K |
| 2 |
Renaissance Technologies
New York
|
+$233K |
| 3 |
BlackRock
New York
|
+$121K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$101K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$45.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.04M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$768K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$15K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EAM
26
Evanson Asset Management
Carmel,
California
| $5K | +$2.72K | +21 | New |
|
|
VCM
27
Vigilant Capital Management
Portland,
Maine
| $4K | +$2.2K | +17 | New |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$259 | +2 | +25% |
|
|
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.03K | +$519 | +4 | New |
|
|
LTFS
30
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | -$519 | -4 | -67% |
|
|
CP
31
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | – | – | – |
|
|
ASN
32
Advisory Services Network
Atlanta,
Georgia
| $1K | +$259 | +2 | New |
|
|
SM
33
Sabby Management
Miami Beach,
Florida
| – | -$1.04M | -15,264 | Closed |
|
|
AFM
34
Anson Funds Management
Dallas,
Texas
| – | -$768K | -11,270 | Closed |
|
|
TSS
35
Two Sigma Securities
New York
| – | -$15K | -227 | Closed |
|
|
TRCT
36
Tower Research Capital (TRC)
New York
| – | -$4K | -63 | Closed |
|
|
37
UBS Group
Zurich,
Switzerland
| – | -$4K | -62 | Closed |
|
|
ICOA
38
Investment Centers of America
Bismarck,
North Dakota
| – | -$2K | -36 | Closed |
|
IRD Hedge Fund Activity: Q1 2017 in Review
33 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2017, worth a combined $7.3M — up 128% from $3.2M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new IRD positions and 6 closed out — a net gain of 5 holders — while 10 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $793K. The largest seller was Sabby Management, exiting entirely with an estimated $1.04M sold.
- 33 institutional investors held Opus Genetics (IRD) as of Q1 2017, up from 31 in Q4 2016.
- Funds reported $7.3M of Opus Genetics stock for Q1 2017, up 128% quarter-over-quarter.
- 11 funds opened new Opus Genetics positions in Q1 2017 and 6 closed out, a net change of +5 holders.
- The largest Opus Genetics buyer in Q1 2017 was Vanguard Group, an estimated $793K added.
- The largest Opus Genetics seller in Q1 2017 was Sabby Management, an estimated $1.04M sold.
Based on aggregated 13F filings for Q1 2017.